ID

12026

Descrizione

A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes; ODM derived from: https://clinicaltrials.gov/show/NCT01950468 Principal Investigator: Stephen Flitman, M.D and Ira Goodman, M.D

collegamento

https://clinicaltrials.gov/show/NCT01950468

Keywords

versioni (1)
  1. 01/09/15 01/09/15 -
Caricato su

1 settembre 2015

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Parkinson's Syndrome NCT01950468

Inglese

Eligibility Parkinson's Syndrome NCT01950468

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
Subject has provided written informed consent before the initiation of any study related procedures and continues to give willing consent for participation
Descrizione

Subject has provided written informed consent before the initiation of any study related procedures and continues to give willing consent for participation

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
Age ≥ 40 years
Descrizione

Age ≥ 40 years

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
Have had upper extremity tremor for < 3 years duration, regardless of presumed diagnosis or etiology
Descrizione

Have had upper extremity tremor for < 3 years duration, regardless of presumed diagnosis or etiology

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0239412
Have a UPDRS part III score upon entry of ≤ 16
Descrizione

UPDRS score

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3827698
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Any clinically significant or unstable physical or psychological illness based on medical history or physical examination at screening, as determined by the investigator
Descrizione

Any clinically significant or unstable physical or psychological illness based on medical history or physical examination at screening, as determined by the investigator

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0205485
UMLS CUI [2]
C1658764
Structural brain abnormality affecting the entire brain (e.g., normal pressure hydrocephalus) or the striatum (e.g., local tumor or stroke)
Descrizione

Structural brain abnormality affecting the entire brain (e.g., normal pressure hydrocephalus) or the striatum (e.g., local tumor or stroke)

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0006111
Any clinically significant abnormal laboratory results obtained at screening and as determined by the investigator
Descrizione

Any clinically significant abnormal laboratory results obtained at screening and as determined by the investigator

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1254595
UMLS CUI [2]
C0205161
Any clinically significant abnormal electrocardiogram (ECG) results obtained at screening and as determined by the investigator
Descrizione

Any clinically significant abnormal electrocardiogram (ECG) results obtained at screening and as determined by the investigator

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2826714
UMLS CUI [2]
C0205161
Any history of drug, narcotic, or alcohol abuse within 2 years before the date of informed consent, as defined by the Diagnostic and Statistical Manual of the American Psychiatric Association, Fourth Edition, revised (DSM-IV-TR [American Psychiatric Association, 1994])
Descrizione

Any history of drug, narcotic, or alcohol abuse within 2 years before the date of informed consent, as defined by the Diagnostic and Statistical Manual of the American Psychiatric Association, Fourth Edition, revised (DSM-IV-TR [American Psychiatric Association, 1994])

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013146
Positive urine drug screen for opiates, cocaine, or amphetamines at screening
Descrizione

Positive urine drug screen for opiates, cocaine, or amphetamines at screening

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0743300
Positive pregnancy test before imaging
Descrizione

Positive pregnancy test before imaging

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0240802
Participation in an investigational drug or device clinical trial within 30 days before the date of informed consent
Descrizione

Participation in an investigational drug or device clinical trial within 30 days before the date of informed consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0679823
UMLS CUI [2]
C0008976
Previous scan with any DAT imaging agent (e.g. [123I]NAV5001, Altropane, DaTscan, DOPASCAN)
Descrizione

Previous scan with any DAT imaging agent (e.g. [123I]NAV5001, Altropane, DaTscan, DOPASCAN)

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1512628
Any exposure to radiopharmaceuticals within 30 days before the date of informed consent
Descrizione

Any exposure to radiopharmaceuticals within 30 days before the date of informed consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0182638
Breast-feeding
Descrizione

Breast-feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0006147
Inability to lie supine for 1 hour
Descrizione

Inability to lie supine for 1 hour

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0038846
Any thyroid disease other than adequately treated hypothyroidism
Descrizione

Any thyroid disease other than adequately treated hypothyroidism

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0040128
Known sensitivity or allergy to iodine or iodine containing products
Descrizione

Known sensitivity or allergy to iodine or iodine containing products

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0571818
UMLS CUI [2]
C0571817
Treatment within the 30 days before the date of imaging with amoxapine, amphetamine, benztropine, bupropion, buspirone, cocaine, mazindol, methamphetamine, methylphenidate, norephedrine, phentermine, phenylpropanolamine, selegiline, and sertraline, paroxetine, or citalopram.
Descrizione

Treatment within the 30 days before the date of imaging with amoxapine, amphetamine, benztropine, bupropion, buspirone, cocaine, mazindol, methamphetamine, methylphenidate, norephedrine, phentermine, phenylpropanolamine, selegiline, and sertraline, paroxetine, or citalopram.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1323365
UMLS CUI [2]
C1254351
Ritorna all'inizio della pagina

Similar models

Eligibility Parkinson's Syndrome NCT01950468

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
informed consent
Item
Subject has provided written informed consent before the initiation of any study related procedures and continues to give willing consent for participation
boolean
C0021430 (UMLS CUI [1])
age
Item
Age ≥ 40 years
boolean
C0001779 (UMLS CUI [1])
EXTREMITY TREMOR, UPPER
Item
Have had upper extremity tremor for < 3 years duration, regardless of presumed diagnosis or etiology
boolean
C0239412 (UMLS CUI [1])
UPDRS score
Item
Have a UPDRS part III score upon entry of ≤ 16
boolean
C3827698 (UMLS CUI [1])
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
physical;psychological disease
Item
Any clinically significant or unstable physical or psychological illness based on medical history or physical examination at screening, as determined by the investigator
boolean
C0205485 (UMLS CUI [1])
C1658764 (UMLS CUI [2])
Brain Diseases
Item
Structural brain abnormality affecting the entire brain (e.g., normal pressure hydrocephalus) or the striatum (e.g., local tumor or stroke)
boolean
C0006111 (UMLS CUI [1])
laboratory results;Abnormal
Item
Any clinically significant abnormal laboratory results obtained at screening and as determined by the investigator
boolean
C1254595 (UMLS CUI [1])
C0205161 (UMLS CUI [2])
electrocardiogram results; abnormal
Item
Any clinically significant abnormal electrocardiogram (ECG) results obtained at screening and as determined by the investigator
boolean
C2826714 (UMLS CUI [1])
C0205161 (UMLS CUI [2])
drug abuse
Item
Any history of drug, narcotic, or alcohol abuse within 2 years before the date of informed consent, as defined by the Diagnostic and Statistical Manual of the American Psychiatric Association, Fourth Edition, revised (DSM-IV-TR [American Psychiatric Association, 1994])
boolean
C0013146 (UMLS CUI [1])
Urine drug screen positive
Item
Positive urine drug screen for opiates, cocaine, or amphetamines at screening
boolean
C0743300 (UMLS CUI [1])
positive pregnancy test
Item
Positive pregnancy test before imaging
boolean
C0240802 (UMLS CUI [1])
Participation; Clinical Trials
Item
Participation in an investigational drug or device clinical trial within 30 days before the date of informed consent
boolean
C0679823 (UMLS CUI [1])
C0008976 (UMLS CUI [2])
Imaging Agent
Item
Previous scan with any DAT imaging agent (e.g. [123I]NAV5001, Altropane, DaTscan, DOPASCAN)
boolean
C1512628 (UMLS CUI [1])
radiopharmaceuticals
Item
Any exposure to radiopharmaceuticals within 30 days before the date of informed consent
boolean
C0182638 (UMLS CUI [1])
Breast-feeding
Item
Breast-feeding
boolean
C0006147 (UMLS CUI [1])
Supine Position
Item
Inability to lie supine for 1 hour
boolean
C0038846 (UMLS CUI [1])
thyroid disease;
Item
Any thyroid disease other than adequately treated hypothyroidism
boolean
C0040128 (UMLS CUI [1])
Iodine allergy; Iodine compounds allergy
Item
Known sensitivity or allergy to iodine or iodine containing products
boolean
C0571818 (UMLS CUI [1])
C0571817 (UMLS CUI [2])
dopamine receptor binding;Pharmacologic Substance
Item
Treatment within the 30 days before the date of imaging with amoxapine, amphetamine, benztropine, bupropion, buspirone, cocaine, mazindol, methamphetamine, methylphenidate, norephedrine, phentermine, phenylpropanolamine, selegiline, and sertraline, paroxetine, or citalopram.
boolean
C1323365 (UMLS CUI [1])
C1254351 (UMLS CUI [2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial